Altium Announces Exclusive Partnership with Cytosurge for FluidFM Technology Distribution in North America
We are thrilled to announce Altium’s new partnership with Cytosurge, a global leader in precision technologies for single-cell research. As November 2024, Altium will distribute Cytosurge’s groundbreaking FluidFM® technology across North America, marking an exciting milestone in expanding innovative research tools to scientists and labs focused on single-cell analysis with an emphasis on gene expression profiles.
Cytosurge’s FluidFM technology offers unparalleled capabilities in live-cell manipulation, enabling researchers to explore cellular mechanisms with precision and control. Key applications include temporal single-cell profiling, which empowers scientists to conduct non-destructive cytoplasmic biopsies, keeping cells alive while gathering valuable gene expression data over time. This temporal approach provides direct insights into cellular dynamics, a significant advancement over traditional static sequencing.
This partnership enables Altium to provide North American researchers with access to FluidFM’s unique single-cell profiling, CRISPR cell line engineering, and microbiome research tools, addressing pressing research needs in cancer development, drug resistance, and disease progression. Together with Cytosurge, Altium is motivated in setting new standards for precision in life sciences, supporting scientific discoveries that improve health outcomes and patient care.
Stay tuned for more updates as we work to advance single-cell research in North America.
Key Partner PHI Begins Trading on the OTCQB Venture Market in the U.S.
A key partner for Altium, Phase Holographic Imaging (PHI), has officially announced that it’s trading on the OTCQB Venture Market under the symbol “PHIXF” as of August 15th. This listing marks a significant achievement in PHI’s mission to expand its presence and engage more effectively with U.S. investors.
For our customers and community, this development represents a strengthened commitment to the North American market. With PHI’s listing on OTCQB, U.S. and Canadian customers can expect increased accessibility and transparency, making it easier to stay informed about the company’s growth and innovations. At Altium, we are fully prepared to meet the anticipated rise in demand for PHI’s cutting-edge holographic imaging products.
Our readiness to supply PHI’s products means that customers can continue to rely on Altium as their trusted partner in the rapidly advancing field of holographic imaging. We are committed to ensuring that our research community has access to the latest technologies and support they need to succeed.
This step forward underscores PHI’s dedication to expanding its reach and engagement with the North American user-base, paving the way for future growth and collaboration.
For more information on the PHI M4 Holomonitor, download the Holomonitor brochure or contact us at info.us@altium.net.
Assistant Professor, University of Michigan-Dearborn, USA
An interview with Dr. Besa Xhabija, Assistant Professor, University of Michigan-Dearborn, USA, as she discusses her use of the HoloMonitor system and AI tools in cancer research. She describes how non-invasive time-lapse imaging aids her breast cancer cell studies, allowing her to observe cellular behaviors and morphological changes affected by natural compounds and environmental toxins. The interview also delves into her recent publication, Kaniski et al. (2024).
Dr. Xhabija elaborates on how she incorporates the system into her workflow, enhancing both efficiency and data quality. She highlights the advantages of utilizing AI to maximize the extensive data generated by HoloMonitor. The conversation covers both technical aspects and broader implications, exploring how single-cell analysis and AI tools could significantly impact cancer research and regenerative medicine.
Altium Partners with Genmark to bring their geneMAP PCR Diagnostic Kits to the US
We are thrilled to announce our first product family offering in the clinical and diagnostic space, reflecting our dedication to expanding our portfolio to offer a wide range of products to our Life Science community. As of April 2024, Altium has become the US supplier for Genmark’s comprehensive portfolio of GeneMap PCR Diagnostic Kits. We look forward to working closely with diagnostic labs across the US to provide high-quality products at competitive prices.
Genmark Saglik is renowned for advancing molecular diagnostics and providing high-quality solutions that guide critical healthcare decisions. With over 60 products Genmark’s expertise spans oncology, genetics, and microbiology. This partnership aligns with our commitment to delivering top-tier diagnostic solutions to healthcare professionals across the United States.
For more information on our product offerings, download geneMAP Brochrue or contact us at info.us@altium.net.
Altium Expands Into in vivo Imaging with Vieworks Partnership
We are proud to announce that as of January 2024, Altium has partnered with Vieworks to represent their Bio Imaging product portfolio in the US and Canada. Vieworks is a leader in advanced imaging technologies, offering high-performance solutions such as their VISQUE® InVivo Systems for preclinical imaging and LUCEON digital pathology slide scanners. This collaboration marks another milestone in our commitment to providing state-of-the-art tools to the research sector in the pre-clinical space.
This collaboration introduces the VISQUE® InVivo Systems, which are advanced preclinical in vivo imaging solutions. The VISQUE® InVivo Series offers high-resolution fluorescent and bioluminescent imaging with features like -90°C cooling for enhanced sensitivity, time-lapse imaging, and intelligent analysis software, making it ideal for applications such as drug biodistribution, pharmacokinetics, and tumor tracking.
We are thrilled to share a significant development that marks an exciting chapter in our journey. We are excited to announce that Nexus Scientific is now a part of the Altium family. This strategic move brings a wealth of new opportunities and avenues for us to better serve you. As a result of this acquisition, our company’s name will transition to Altium International Inc.
For the past several years, Nexus Scientific has been your go-to partner for cutting edge life science research equipment. Our commitment to bettering our community has been the driving force behind our offerings, catering to your unique needs in the ever-evolving landscape of laboratory research.
With a product range spanning advanced imaging platforms to cutting-edge cell research platforms, we have been at the forefront of facilitating breakthroughs in cellular research and beyond.
Starting from August 2023, all official communications, invoices, and interactions will carry our new name, Altium International Inc. Despite this change, our core values, the expertise of our team, and our unwavering dedication to supporting your pursuits remain unchanged.
It’s important to note that this transition will not impact our team, management, or our operations. We will continue to operate from our existing locations, ensuring that you receive the same exceptional service you’ve come to expect from us.
If you have any questions or need further information about this transition, please don’t hesitate to reach out to selen.oztunaoglu@altium.net or (857) 264 6884. Our team is here to provide the answers you seek and the support you deserve.
Your trust and partnership have been pivotal to our growth, and we want to thank you for your continued support. We look forward to serving you even better as Altium International Inc., and we invite you to embark on this exciting journey with us.
Thank you for being an integral part of Nexus Scientific’s story, and we can’t wait to continue this journey together as Altium.
Today, Phasefocus and Nexus Scientific announced a partnership to accelerate the adoption of Livecyte, a high content live cell analyser, in the US market. Live cell imaging is essential to answering some of the most pressing questions in the life sciences, but conventional methods often involve labeling cells, a potentially harmful process that can alter research outcomes. Livecyte’s integration of patented label-free Quantitative Phase Imaging technology with state-of-the-art automatic cell tracking algorithms enables users to automatically characterize growth, morphology and motility of large populations of cells in a 96-well plate assay format.
Nexus brings extensive experience in the cell analysis sector to the partnership, with a portfolio of cutting-edge live cell imaging and analysis tools. With the addition of Livecyte, Nexus can offer researchers a unique depth of live cell analysis capabilities in application areas such as drug discovery, regenerative medicine and cell-based assays.
Phasefocus CEO, Martin Humphry commented: “We are very excited to be embarking on a new adventure with the fantastic team at Nexus Scientific. Their extensive sector knowledge and talented team are a great complement to Phasefocus. The partnership will help us grow our US customer base and bring the unique capabilities of Livecyte to a new audience.”
“We are proud to be adding the ground-breaking Livecyte to our growing live cell imaging and analysis portfolio” added Selen Oztunaoglu, Managing Director at Nexus Scientific. “With Livecyte’s unique and powerful capabilities, we get to address a wider range of customers’ pain points and they’ll will be able to enjoy new depths of insights and push the boundaries of knowledge even further.”
About Nexus Scientific
Nexus Scientific is a Life Science Equipment Supplier headquartered in Boston, MA. We provide International Trade, US Distribution of Equipment as well as pre-sale to post-sale support. Our customers range from Academic Research groups to Hospitals, Biotech and Pharmaceutical companies.
Working with Innovative brands and disruptive technologies is at the core of Nexus’s partnerships. Its mission is to enable scientists to further their research by ensuring ease of access to leading edge laboratory and research equipment. Nexus Scientific provides an opportunity for innovative life science brands to grow their global presence.
Phasefocus is changing what is possible in live cell assays, helping scientists uncover subtle differences in cell behaviour across whole cell populations. The company’s products are based on a patented and award-winning computational imaging technology, called ptychography. From automated characterisation of live cell behaviour to world-record-setting electron microscopy, Phasefocus is enabling advances in many diverse areas of scientific research.
Livecyte, Phasefocus’s flagship product, delivers an unprecedented level of single-cell data from live cells. High-contrast label-free imaging, correlative fluorescence and powerful automated image analysis algorithms result in high-content time-lapse outputs from standard 96-well plate assays.
